← Back
$ACHV All transactions

ACHIEVE LIFE SCIENCES, INC.

M

$ Value

$0

Shares

455,000

Price

$0

Filed

Sep 8

Insider

Name

KING THOMAS BRAXTON

Title

CIK

0001279309

Roles

Director

Transaction Details

Transaction Date

2025-09-04

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

Represents shares of common stock acquired upon settlement of the performance restricted stock units ("PRSUs") listed in Table II. | Represents shares of common stock that have been sold by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the PRSUs. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.68 to $2.88 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | Represents PRSUs previously reported on January 14, 2025 that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors. | Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. | Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones.

Filing Info

Accession No.

0000950170-25-113591

Form Type

4

Issuer CIK

0000949858

KING THOMAS BRAXTON's History

Date Ticker Type Value
2025-09-04 ACHV M $0
2025-09-04 ACHV $387K
2025-09-04 ACHV M $0
2025-06-06 ACHV A $0

Other Insiders at ACHV (90d)

Insider Bought Sold Last
Oki Mark K
Chief Financial Officer
2026-01-28
Stewart Richard Alistair
Chief Executive Officer
2026-01-28
Goldberg Andrew D.
CEO and President
2026-04-18
Wan Jerry
Principal Accounting Officer
2026-01-28
Xinos Jaime
Chief Commercial Officer
2026-01-28
Donnelly Craig
Chief Operations Officer
2026-01-28
Rubinstein Mark Lawrence
Chief Medical Officer
2026-01-28